MSH2 and Lynch syndrome: In the present study, we examined patients with a tumour that indicated possible Lynch syndrome for germline mutations in the MMR genes MLH1, MSH2, MSH6, and PMS2. In addition, we tested tumour DNA for hypermethylation of the MLH1 promoter.